Literature DB >> 23714323

Prevalence of blindness and outcomes of cataract surgery in Hainan Province in South China.

Emmy Y Li1, Yingpeng Liu, Xingkai Zhan, Yuan Bo Liang, Xiujuan Zhang, Chongren Zheng, Vishal Jhanji, Ping Xu, David F Chang, Dennis S C Lam.   

Abstract

OBJECTIVE: To define the prevalence of blindness and visual impairment (VI) in people in rural Hainan using the rapid assessment of avoidable blindness (RAAB) and to report the outcomes of cataract surgery among the residents.
DESIGN: Population-based, cross-sectional survey. PARTICIPANTS: A total of 6482 rural residents of the Hainan province.
METHODS: A total of 136 clusters, each of which consisted of 50 people aged ≥50 years, were selected through probability-proportionate-to-size sampling. Door-to-door visits were performed by 2 outreach teams. Visual acuity (VA) was measured on site, and those with VA <6/18 in either eye were examined by an ophthalmologist. Causes of blindness and VI were determined. The causes of poor visual outcome after cataract surgery were evaluated. Information regarding barriers to receiving surgery was collected by trained interviewers. MAIN OUTCOME MEASURES: Prevalence and causes of blindness (VA <3/60), severe VI (SVI) (VA <6/60 but ≥3/60), and VI (VA <6/18 but ≥6/60) based on presenting VA (PVA) were assessed. Outcomes of cataract surgery performed in public and private hospitals and charitable organizations were compared.
RESULTS: A total of 6482 subjects were examined (response rate, 95.3%). The sample prevalence of blindness was 4.4% (95% confidence interval [CI], 2.0-6.8). The prevalence of SVI and VI was 1.9% (95% CI, 0-4.3) and 9.9% (95% CI, 7.6-12.2), respectively. Age and sex were associated with increased prevalence of blindness, SVI, and VI. Overall, cataract accounted for approximately 60% of blindness and SVI. Of the 524 eyes that had received cataract surgery, 87.2% had intraocular lenses implanted, 21% had a poor visual outcome (PVA <6 /60), and 20% had a borderline visual outcome (PVA <6/18 but ≥6/60). Eyes that received surgery in charitable organizations had a higher rate of intraocular lens implantation and good visual outcome (VA ≥6/18) compared with eyes that were operated on elsewhere.
CONCLUSIONS: The prevalence of blindness, SVI, and VI was high among rural residents in Hainan. Cataract remained the leading cause of avoidable blindness. Outcomes of cataract surgery performed in public hospitals were suboptimal. Quality-control initiatives should be introduced to improve cataract surgery outcomes.
Copyright © 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23714323     DOI: 10.1016/j.ophtha.2013.04.003

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Prevalence of Vision Impairment in Older Adults in Rural China in 2014 and Comparisons With the 2006 China Nine-Province Survey.

Authors:  Jialiang Zhao; Xiao Xu; Leon B Ellwein; Ning Cai; Huaijin Guan; Mingguang He; Ping Liu; Jianhua Lv; Xunlun Sheng; Peizeng Yang; Jinglin Yi; Mei Yang; Rui Zhang; Xiaohu Ding; Liping Du; Fengrong Li; Hong Lu; Wenqiang Shao; Junwei Wang; Yuansheng Yuan; Rui Zhou; Wenjuan Zhuang; Lei An
Journal:  Am J Ophthalmol       Date:  2017-11-02       Impact factor: 5.258

2.  Prevalence of visual impairment and outcomes of cataract surgery in Chaonan, South China.

Authors:  Xiujuan Zhang; Emmy Y Li; Christopher Kai-Shun Leung; David C Musch; Xin Tang; Chongren Zheng; Mingguang He; David F Chang; Dennis Shun-Chiu Lam
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

3.  Visual Impairment among Older Adults in a Rural Community in Eastern China.

Authors:  Chen-Wei Pan; Deng-Juan Qian; Hong-Peng Sun; Qinghua Ma; Yong Xu; E Song
Journal:  J Ophthalmol       Date:  2016-09-29       Impact factor: 1.909

4.  Prevalence and causes of blindness, visual impairment among different ethnical minority groups in Xinjiang Uygur autonomous region, China.

Authors:  Yanping Li; Wenyong Huang; Aoyun Qiqige; Hongwei Zhang; Ling Jin; Pula Ti; Jennifer Yip; Baixiang Xiao
Journal:  BMC Ophthalmol       Date:  2018-02-13       Impact factor: 2.209

5.  Blindness and eye disease in a Tibetan region of China: findings from a Rapid Assessment of Avoidable Blindness survey.

Authors:  Danba Jiachu; Feng Jiang; Li Luo; Hong Zheng; Ji Duo; Jing Yang; Yongcuo Nima; Jin Ling; Baixiang Xiao; Ken Bassett
Journal:  BMJ Open Ophthalmol       Date:  2018-11-17

6.  Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII).

Authors:  Fiona L M Chew; Mohamad Aziz Salowi; Zuraidah Mustari; Mohd Aziz Husni; Elias Hussein; Tassha Hilda Adnan; Nor Fariza Ngah; Hans Limburg; Pik-Pin Goh
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

7.  The Association of Outdoor Activity and Age-Related Cataract in a Rural Population of Taizhou Eye Study: Phase 1 Report.

Authors:  Yating Tang; Yinghong Ji; Xiaofang Ye; Xiaofeng Wang; Lei Cai; Jianming Xu; Yi Lu
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

8.  A survey of perceived training differences between ophthalmology residents in Hong Kong and China.

Authors:  Alvin L Young; Vishal Jhanji; Yuanbo Liang; Nathan Congdon; Simon Chow; Fenghua Wang; Xiujuan Zhang; Xiaofei Man; Mingming Yang; Zhong Lin; Hunter G L Yuen; Dennis S C Lam
Journal:  BMC Med Educ       Date:  2015-09-28       Impact factor: 2.463

9.  Diosgenin from Dioscorea bulbifera: novel hit for treatment of type II diabetes mellitus with inhibitory activity against α-amylase and α-glucosidase.

Authors:  Sougata Ghosh; Piyush More; Abhishek Derle; Ajay B Patil; Pramod Markad; Adersh Asok; Navanath Kumbhar; Mahemud L Shaikh; Boppana Ramanamurthy; Vaishali S Shinde; Dilip D Dhavale; Balu A Chopade
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

10.  Prevalence and Causes of Visual Impairment in Adults in Binhu District, Wuxi, China.

Authors:  Xing Chen; Danying Zhou; Jian Shen; Yanbing Wu; Qingzhu Sun; Jianming Dong; Jianchun Yu
Journal:  Med Sci Monit       Date:  2018-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.